CollPlant Biotechnologies (CLGN) Net Margin (2017 - 2025)
CollPlant Biotechnologies filings provide 9 years of Net Margin readings, the most recent being 4701.67% for Q4 2025.
- On a quarterly basis, Net Margin fell 239557.0% to 4701.67% in Q4 2025 year-over-year; TTM through Dec 2025 was 54.07%, a 20184.0% decrease, with the full-year FY2025 number at 468.28%, up 273812.0% from a year prior.
- Net Margin hit 4701.67% in Q4 2025 for CollPlant Biotechnologies, down from 4523.38% in the prior quarter.
- In the past five years, Net Margin ranged from a high of 4554.08% in Q1 2024 to a low of 108150.0% in Q3 2024.
- Median Net Margin over the past 5 years was 442.11% (2021), compared with a mean of 6775.58%.
- Biggest five-year swings in Net Margin: tumbled -26170145bps in 2021 and later surged 10362662bps in 2025.
- CollPlant Biotechnologies' Net Margin stood at 1227.1% in 2021, then crashed by -557bps to 8062.07% in 2022, then skyrocketed by 82bps to 1469.57% in 2023, then tumbled by -57bps to 2306.1% in 2024, then plummeted by -104bps to 4701.67% in 2025.
- The last three reported values for Net Margin were 4701.67% (Q4 2025), 4523.38% (Q3 2025), and 1775.42% (Q2 2025) per Business Quant data.